Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.990
-0.120 (-2.92%)
At close: Sep 4, 2026, 4:00 PM EDT
4.020
+0.030 (0.75%)
After-hours: Sep 4, 2026, 7:41 PM EDT
Zentalis Pharmaceuticals Employees
Zentalis Pharmaceuticals had 106 employees as of December 31, 2025. The number of employees decreased by 60 or -36.14% compared to the previous year.
Employees
106
Change (1Y)
-60
Growth (1Y)
-36.14%
Revenue / Employee
n/a
Profits / Employee
-$1,316,462
Market Cap
377.74M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 106 | -60 | -36.14% |
| Dec 31, 2024 | 166 | -2 | -1.19% |
| Dec 31, 2023 | 168 | 12 | 7.69% |
| Dec 31, 2022 | 156 | -21 | -11.86% |
| Dec 31, 2021 | 177 | 53 | 42.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EyePoint | 214 |
| Lyell Immunopharma | 161 |
| Agenus | 81 |
| Century Therapeutics | 78 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 63 |
| X4 Pharmaceuticals | 45 |
| DiaMedica Therapeutics | 35 |
ZNTL News
- 4 days ago - Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 days ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 22 days ago - Zentalis announecs common stock offering, no amount given - TheFly
- 24 days ago - Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering - GlobeNewsWire
- 24 days ago - Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering - GlobeNewsWire
- 4 weeks ago - Zentalis price target raised to $5 from $4 at Morgan Stanley - TheFly
- 4 weeks ago - Zentalis Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire